{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:45:21Z","timestamp":1787071521605,"version":"build-2736575974"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background and Objectives:<\/jats:title>\n                    <jats:p>Oral squamous cell carcinoma (OSCC) is one of the most common cancers globally, accounting for a significant portion of head and neck malignancies. Most cases are preceded by oral potentially malignant disorders (OPMD), which may progress through histological changes such as hyperplasia, hyperkeratosis, and oral epithelial dysplasia (OED). A key factor in this progression is immune evasion, particularly through the PD-1\/PD-L1 pathway, which tumour cells exploit to escape immune surveillance. Although therapeutic strategies targeting PD-1\/PD-L1 are promising, their expression patterns and prognostic significance in OED and OSCC remain underexplored. This study aimed to evaluate and compare the immunohistochemical expression of PD-1 and PD-L1 in OED and OSCC, including their different grades.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>An analytical cross-sectional study was conducted with 66 samples (33 each of OED and OSCC). Diagnoses were confirmed histopathologically. Samples were stained using immunohistochemistry for PD-1 and PD-L1, and expression was assessed using the immunoreactivity score (IRS). Statistical analysis was performed using SPSS version 20.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results and Discussion:<\/jats:title>\n                    <jats:p>\n                      PD-1 and PD-L1 expression were significantly higher in OSCC compared with OED (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). Expression levels increased progressively with higher grades of dysplasia and poorer tumour differentiation. A positive correlation between PD-1 and PD-L1 expression was observed within both groups, aligning with previous studies.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>These findings highlight the potential role of the PD-1\/PD-L1 axis in early tumour development and immune evasion. Further research with larger sample sizes and clinical correlation could establish PD-1\/PD-L1 as targets for immunotherapy, potentially improving outcomes in advanced OSCC and severe dysplasia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jomfp.jomfp_278_25","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T08:00:27Z","timestamp":1775116827000},"page":"145-152","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Immunohistochemical evaluation of PD-1 and PD-L1 in oral squamous cell carcinoma and oral epithelial dysplasia"],"prefix":"10.4103","volume":"30","author":[{"given":"Somanathan","family":"Anjana","sequence":"first","affiliation":[{"name":"Department of Oral Pathology and Microbiology, Government Dental College, Trivandrum, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajendran","family":"Rajeev","sequence":"additional","affiliation":[{"name":"Department of Oral Pathology and Microbiology, Government Dental College, Trivandrum, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"key":"R1-20260420","first-page":"229","article-title":"Global cancer statistics 2022: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"R2-20260420","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/S0140-6736(05)66658-5","article-title":"Effect of screening on oral cancer mortality in Kerala, India: A cluster-randomised controlled trial","volume":"365","author":"Sankaranarayanan","year":"2005","journal-title":"Lancet"},{"key":"R3-20260420","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4103\/jomfp.JOMFP_13_19","article-title":"Oral epithelial dysplasia: Classifications and clinical relevance in risk assessment of oral potentially malignant disorders","volume":"23","author":"Ranganathan","year":"2019","journal-title":"J Oral Maxillofac Pathol"},{"key":"R4-20260420","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/jop.12339","article-title":"Malignant transformation of oral leukoplakia: A systematic review of observational studies","volume":"45","author":"Warnakulasuriya","year":"2016","journal-title":"J Oral Pathol Med"},{"key":"R5-20260420","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1079-2104(05)80226-4","article-title":"Oral epithelial dysplasia and the development of invasive squamous cell carcinoma","volume":"79","author":"Lumerman","year":"1995","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"R6-20260420","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hed.24589","article-title":"Changing epidemiology of oral squamous cell carcinoma of the tongue: A global study","volume":"39","author":"Ng","year":"2017","journal-title":"Head Neck"},{"key":"R7-20260420","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.coms.2014.01.001","article-title":"Epidemiologic trends in head and neck cancer and aids in diagnosis","volume":"26","author":"Vigneswaran","year":"2014","journal-title":"Oral Maxillofac Surg Clin North Am"},{"key":"R8-20260420","doi-asserted-by":"crossref","first-page":"168","DOI":"10.5114\/ceji.2022.117376","article-title":"Cancer immunoediting hypothesis: History, clinical implications and controversies","volume":"47","author":"Lasek","year":"2022","journal-title":"Cent Eur J Immunol"},{"key":"R9-20260420","doi-asserted-by":"crossref","first-page":"147","DOI":"10.22312\/sdusbed.816756","article-title":"Evaluation of PD1 and PDL1 Expressions in squamous cell carcinoma and lichen planus","volume":"12","author":"Erkilin\u00e7","year":"2021","journal-title":"S\u00fcleyman Demirel \u00dcniversitesi Sa\u011fl\u0131k Bilimleri Dergisi"},{"key":"R11-20260420","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1097\/JTO.0000000000000687","article-title":"Expression of PD-1 and its ligands, PD\u2013L1 and PD-L2, in smokers and never smokers with KRAS-mutant lung cancer","volume":"10","author":"Calles","year":"2015","journal-title":"J Thorac Oncol"},{"key":"R12-20260420","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00262-006-0272-1","article-title":"Contribution of the PD-L1\/PD-1 pathway to T-cell exhaustion: An update on implications for chronic infections and tumor evasion","volume":"56","author":"Blank","year":"2007","journal-title":"Cancer Immunol Immunother"},{"key":"R14-20260420","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1111\/odi.14332","article-title":"Influence of PD-1\/PD-L1 on immune microenvironment in oral leukoplakia and oral squamous cell carcinoma","volume":"29","author":"Xu","year":"2023","journal-title":"Oral Dis"},{"key":"R15-20260420","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s12272-016-0850-5","article-title":"Immune checkpoint inhibitors for cancer treatment","volume":"39","author":"Park","year":"2016","journal-title":"Arch Pharm Res"},{"key":"R16-20260420","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13046-019-1085-3","article-title":"Challenges and potential of PD-1\/PD-L1 checkpoint blockade immunotherapy for glioblastoma","volume":"38","author":"Wang","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"R17-20260420","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3390\/biomedicines9020194","article-title":"Importance of the PD-1\/PD-L1 axis for malignant transformation and risk assessment of oral leukoplakia","volume":"9","author":"Ries","year":"2021","journal-title":"Biomedicines"},{"key":"R18-20260420","doi-asserted-by":"crossref","first-page":"eabd2712","DOI":"10.1126\/sciadv.abd2712","article-title":"Revisiting the PD-1 pathway","volume":"6","author":"Patsoukis","year":"2020","journal-title":"Sci Adv"},{"key":"R19-20260420","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1136\/jclinpath-2020-206832","article-title":"PD-L1 expression by tumor proportion score (TPS) and combined positive score (CPS) are similar in non-small cell lung cancer (NSCLC)","volume":"74","author":"De Marchi","year":"2021","journal-title":"J Clin Pathol"},{"key":"R20-20260420","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/his.12662","article-title":"Comparison of immunoreactive score, HER2\/neu score and H score for the immunohistochemical evaluation of somatostatin receptors in bronchopulmonary neuroendocrine neoplasms","volume":"67","author":"Specht","year":"2015","journal-title":"Histopathology"},{"key":"R21-20260420","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jcms.2017.04.013","article-title":"Expression of immunoregulatory molecules PD-L1 and PD-1 in oral cancer and precancerous lesions: A cohort study of Japanese patients","volume":"47","author":"Kouketsu","year":"2019","journal-title":"J Craniomaxillofac Surg"},{"key":"R22-20260420","doi-asserted-by":"crossref","first-page":"9705","DOI":"10.1038\/s41598-020-66257-6","article-title":"Increased expression of PD-1 and PD-L1 in oral lesions progressing to oral squamous cell carcinoma: A pilot study","volume":"10","author":"Dave","year":"2020","journal-title":"Sci Rep"},{"key":"R23-20260420","doi-asserted-by":"crossref","first-page":"6580","DOI":"10.1158\/1078-0432.CCR-12-1362","article-title":"Molecular pathways: Next-generation immunotherapy--inhibiting programmed death-ligand 1 and programmed death-1","volume":"18","author":"Chen","year":"2012","journal-title":"Clin Cancer Res"},{"key":"R24-20260420","doi-asserted-by":"crossref","first-page":"21698","DOI":"10.1038\/s41598-023-48572-w","article-title":"Correlation of PD-1 and PD-L1 expression in oral leukoplakia and oral squamous cell carcinoma: An immunohistochemical study","volume":"13","author":"Greeshma","year":"2023","journal-title":"Sci Rep"},{"key":"R25-20260420","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.ijom.2018.01.004","article-title":"Significant association of increased PD-L1 and PD-1 expression with nodal metastasis and a poor prognosis in oral squamous cell carcinoma","volume":"47","author":"Maruse","year":"2018","journal-title":"Int J Oral Maxillofac Surg"},{"key":"R26-20260420","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.joms.2016.11.006","article-title":"Is there evidence for the presence and relevance of the PD-1\/PD-L1 pathway in oral squamous cell carcinoma? Hints from an immunohistochemical study","volume":"75","author":"Troeltzsch","year":"2017","journal-title":"J Oral Maxillofac Surg"},{"key":"R27-20260420","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/ijc.30770","article-title":"The PD-1\/PD-L1 axis and human papilloma virus in patients with head and neck cancer after adjuvant chemoradiotherapy: A multicentre study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG): PD\u20131\/PD-L1 axis and HPV in patients with head and neck cancer after adjuvant CRT","volume":"141","author":"Balermpas","year":"2017","journal-title":"Int J Cancer"},{"key":"R28-20260420","doi-asserted-by":"crossref","first-page":"152418","DOI":"10.1016\/j.prp.2019.04.010","article-title":"Expression of programmed cell death-ligand 1 in oral squamous cell carcinoma and oral leukoplakia is associated with disease progress and CD8+ tumor-infiltrating lymphocytes","volume":"215","author":"Chen","year":"2019","journal-title":"Pathol Res Pract"},{"key":"R29-20260420","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/apm.12881","article-title":"CD8+ and CD163+ infiltrating cells and PD-L1 immunoexpression in oral leukoplakia and oral carcinoma","volume":"126","author":"Stasikowska-Kanicka","year":"2018","journal-title":"APMIS"},{"key":"R30-20260420","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.humimm.2017.09.003","article-title":"Overexpression of immunomodulatory mediators in oral precancerous lesions","volume":"78","author":"Gon\u00e7alves","year":"2017","journal-title":"Hum Immunol"},{"key":"R31-20260420","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.oraloncology.2017.03.006","article-title":"Programmed death ligand 1 (PD-L1) expression and tumor microenvironment: Implications for patients with oral precancerous lesions","volume":"68","author":"Yagyuu","year":"2017","journal-title":"Oral Oncol"},{"key":"R32-20260420","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.oraloncology.2011.08.007","article-title":"Relationship between the expressions of PD-L1 and tumor-infiltrating lymphocytes in oral squamous cell carcinoma","volume":"47","author":"Cho","year":"2011","journal-title":"Oral Oncol"},{"key":"R33-20260420","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.31557\/APJCP.2022.23.12.4039","article-title":"Comparison of PD-L1 expression in oral squamous cell carcinoma and premalignant lesions of oral cavity","volume":"23","author":"Saeed","year":"2022","journal-title":"Asian Pac J Cancer Prev"},{"key":"R34-20260420","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.oooo.2019.07.008","article-title":"Association of PD-L1 expression in oral squamous cell carcinoma with smoking, sex, and p53 expression","volume":"128","author":"Ahmadi","year":"2019","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"R35-20260420","doi-asserted-by":"crossref","first-page":"e0269136","DOI":"10.1371\/journal.pone.0269136","article-title":"Differences in PD-L1 expression between oral and oropharyngeal squamous cell carcinoma","volume":"17","author":"Blatt","year":"2022","journal-title":"PLoS One"},{"key":"R36-20260420","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4103\/jomfp.jomfp_339_23","article-title":"Immunohistochemical study of programmed cell death ligand 1 (PDL1) expression by combined positive score using 22C3 clone in head and neck squamous cell carcinomas, its correlation with clinicopathological features and outcome","volume":"28","author":"Gangadhar","year":"2024","journal-title":"J Oral Maxillofac Pathol"},{"key":"R37-20260420","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ijom.2017.09.006","article-title":"Tumor PD-L1 expression is associated with improved survival and lower recurrence risk in young women with oral cavity squamous cell carcinoma","volume":"47","author":"Hanna","year":"2018","journal-title":"Int J Oral Maxillofac Surg"},{"key":"R38-20260420","doi-asserted-by":"crossref","first-page":"e0142656","DOI":"10.1371\/journal.pone.0142656","article-title":"High PD-L1 expression correlates with metastasis and poor prognosis in oral squamous cell carcinoma","volume":"10","author":"Lin","year":"2015","journal-title":"PLoS One"},{"key":"R39-20260420","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/jop.13220","article-title":"Challenges facing pathologists evaluating PD-L1 in head and neck squamous cell carcinoma","volume":"50","author":"Girolami","year":"2021","journal-title":"J Oral Pathol Med"},{"key":"R40-20260420","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/s41379-020-0644-7","article-title":"Comparison of three PD-L1 immunohistochemical assays in head and neck squamous cell carcinoma (HNSCC)","volume":"34","author":"de Ruiter","year":"2021","journal-title":"Mod Pathol"},{"key":"R41-20260420","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/cre2.590","article-title":"PD-L1 in oral squamous cell carcinoma: A key biomarker from the laboratory to the bedside","volume":"8","author":"Nocini","year":"2022","journal-title":"Clin Exp Dent Res"},{"key":"R42-20260420","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/s41416-019-0449-y","article-title":"Intratumor heterogeneity of PD-L1 expression in head and neck squamous cell carcinoma","volume":"120","author":"Rasmussen","year":"2019","journal-title":"Br J Cancer"},{"key":"R43-20260420","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s12105-017-0857-3","article-title":"Beyond the percentages of PD-L1-positive tumor cells: Induced versus constitutive PD-L1 expression in primary and metastatic head and neck squamous cell carcinoma","volume":"12","author":"Scognamiglio","year":"2018","journal-title":"Head Neck Pathol"},{"key":"R44-20260420","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.18632\/oncotarget.27563","article-title":"Hyperprogression and impact of tumor growth kinetics after PD1\/PDL1 inhibition in head and neck squamous cell carcinoma","volume":"11","author":"Karabajakian","year":"2020","journal-title":"Oncotarget"}],"container-title":["Journal of Oral and Maxillofacial Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jomfp.jomfp_278_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:47:25Z","timestamp":1787068045000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jomfp.jomfp_278_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/jomfp.jomfp_278_25","relation":{},"ISSN":["0973-029X","1998-393X"],"issn-type":[{"value":"0973-029X","type":"print"},{"value":"1998-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"2025-09-13","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-23","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}